Health
AstraZeneca denies vaccine trial subject had nerve ailment – The Peninsula Qatar
Trials of the Oxford-Astra vaccine resumed in the U.K. over the weekend, after a pause to investigate the adverse event, while researchers in South Africa also restarted tests.
AstraZeneca Plc, the drugmaker working with the University of Oxford on a Covid-19 vaccine, contradicted a report that a volunteer in U.K. tests of the shot developed a rare nerve disease that might have signaled severe safety problems.
AstraZeneca was responding Thursday to a CNN report citing documents indicating that the diagnosis of the participant was confirmed as transverse myelitis. The diagnosis was “based on preliminary findings,” and is inaccurate, the Cambridge, England-based drugmak…
-
General15 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
Noosa News24 hours agoRainbow Beach surfer’s untold 7/7 story
-
Noosa News22 hours agoBarn-owl project reducing farmers’ reliance on poison to manage rats and mice
-
Noosa News14 hours agoWoman airlifted to Brisbane hospital after big cat mauling at south-east Queensland zoo near Toowoomba